This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Diadexus, Inc.. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Innovations by Xiaozhu Duan in Cancer Detection
Introduction
Xiaozhu Duan is an accomplished inventor based in Alameda, CA. She has made significant contributions to the field of cancer detection through her innovative work. Her research focuses on developing methods to assess the risk of prostate and ovarian cancers.
Latest Patents
Xiaozhu Duan holds a patent for her invention titled "Cln101 antibody compositions and methods of use alone and in combination with prostate specific antigen and other cancer markers." This invention relates to a method for assessing the risk of prostate and ovarian cancer. Specifically, it utilizes both Cln101 and Prostate Specific Antigen (PSA) in combination to determine the risk of prostate cancer. In an alternative embodiment, the invention relates to utilizing Cln101 alone or in combination with CA125 to determine the risk of ovarian cancer. The invention also provides isolated anti-prostate or ovarian cancer antigen (Cln101) antibodies that bind to Cln101 in vivo. Additionally, it encompasses compositions comprising an anti-Cln101 antibody and a carrier, which can be provided in an article of manufacture or a kit. Other aspects include an isolated nucleic acid encoding an anti-Cln101 antibody, as well as an expression vector comprising the isolated nucleic acid. The invention also provides methods for producing anti-Cln101 antibodies and treating Cln101-expressing cancers.
Career Highlights
Xiaozhu Duan is currently associated with Diadexus, Inc., where she continues her research and development efforts. Her work has been instrumental in advancing cancer diagnostics and treatment methodologies.
Collaborations
Xiaozhu has collaborated with notable colleagues, including Robert L. Wolfert and Nam Kim, who have contributed to her research endeavors.
Conclusion
Xiaozhu Duan's innovative work in cancer detection through her patented methods showcases her dedication to improving healthcare outcomes. Her contributions are vital in the ongoing fight against cancer, and her research continues to pave the way for future advancements in the field.